Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial

Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2024-11, Vol.103 (10), p.e209868
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 10
container_start_page e209868
container_title Neurology
container_volume 103
description
doi_str_mv 10.1212/WNL.0000000000209868
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3119192131</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3119192131</sourcerecordid><originalsourceid>FETCH-LOGICAL-c186t-8612349e737258ac24505657eecf1f04da004b7318eb0594a0427a0375e2bfe03</originalsourceid><addsrcrecordid>eNpdUclOwzAQtRAIyvIHCPnIgYCXJHaOpZRFKhQVENwix5lQozQutoMEv8BPY9YDc5ntvTfSPIR2KTmkjLKj-6vJIfkLRgqZyxU0oBnLk5yzh1U0iGOZcCnkBtr0_omQuBTFOtrgRcqZFGKA3sdNY7TSr9g2eBjsIyxVF7Dp8GjubGc0vjSPTpkO8L0Jc6y6-quwfcBD3QfAl1BHgWBsh6cv4HoPn-wwBzyLYLswb1Af4BPbVy0kx63pYnc9VxHG8fVsejYb39zgW2dUu43WGtV62PnJW-judHw7Ok8m07OL0XCSaCrzkMicMp4WILhgmVSapRnJ8kwA6IY2JK0VIWklOJVQkaxIFUmZUISLDFjVAOFbaP9bd-nscw8-lAvjNbSt6sD2vuSUFrRglNMITb-h2lnvHTTl0pmFcq8lJeWnDWW0ofxvQ6Tt_VzoqwXUf6Tfv_MP7SeBcA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3119192131</pqid></control><display><type>article</type><title>Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial</title><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><identifier>ISSN: 0028-3878</identifier><identifier>ISSN: 1526-632X</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/WNL.0000000000209868</identifier><identifier>PMID: 39432877</identifier><language>eng</language><publisher>United States</publisher><ispartof>Neurology, 2024-11, Vol.103 (10), p.e209868</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c186t-8612349e737258ac24505657eecf1f04da004b7318eb0594a0427a0375e2bfe03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39432877$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><title>Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial</title><title>Neurology</title><addtitle>Neurology</addtitle><issn>0028-3878</issn><issn>1526-632X</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpdUclOwzAQtRAIyvIHCPnIgYCXJHaOpZRFKhQVENwix5lQozQutoMEv8BPY9YDc5ntvTfSPIR2KTmkjLKj-6vJIfkLRgqZyxU0oBnLk5yzh1U0iGOZcCnkBtr0_omQuBTFOtrgRcqZFGKA3sdNY7TSr9g2eBjsIyxVF7Dp8GjubGc0vjSPTpkO8L0Jc6y6-quwfcBD3QfAl1BHgWBsh6cv4HoPn-wwBzyLYLswb1Af4BPbVy0kx63pYnc9VxHG8fVsejYb39zgW2dUu43WGtV62PnJW-judHw7Ok8m07OL0XCSaCrzkMicMp4WILhgmVSapRnJ8kwA6IY2JK0VIWklOJVQkaxIFUmZUISLDFjVAOFbaP9bd-nscw8-lAvjNbSt6sD2vuSUFrRglNMITb-h2lnvHTTl0pmFcq8lJeWnDWW0ofxvQ6Tt_VzoqwXUf6Tfv_MP7SeBcA</recordid><startdate>20241126</startdate><enddate>20241126</enddate><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20241126</creationdate><title>Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c186t-8612349e737258ac24505657eecf1f04da004b7318eb0594a0427a0375e2bfe03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial</atitle><jtitle>Neurology</jtitle><addtitle>Neurology</addtitle><date>2024-11-26</date><risdate>2024</risdate><volume>103</volume><issue>10</issue><spage>e209868</spage><pages>e209868-</pages><issn>0028-3878</issn><issn>1526-632X</issn><eissn>1526-632X</eissn><cop>United States</cop><pmid>39432877</pmid><doi>10.1212/WNL.0000000000209868</doi></addata></record>
fulltext fulltext
identifier ISSN: 0028-3878
ispartof Neurology, 2024-11, Vol.103 (10), p.e209868
issn 0028-3878
1526-632X
1526-632X
language eng
recordid cdi_proquest_miscellaneous_3119192131
source Journals@Ovid Complete; Alma/SFX Local Collection
title Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T03%3A45%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20Atogepant%20in%20Chronic%20Migraine%20With%20and%20Without%20Acute%20Medication%20Overuse%20in%20the%20Randomized,%20Double-Blind,%20Phase%203%20PROGRESS%20Trial&rft.jtitle=Neurology&rft.date=2024-11-26&rft.volume=103&rft.issue=10&rft.spage=e209868&rft.pages=e209868-&rft.issn=0028-3878&rft.eissn=1526-632X&rft_id=info:doi/10.1212/WNL.0000000000209868&rft_dat=%3Cproquest_cross%3E3119192131%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3119192131&rft_id=info:pmid/39432877&rfr_iscdi=true